Vis enkel innførsel

dc.contributor.authorHøjlund, Mikkel
dc.contributor.authorGudmundsson, Larus S.
dc.contributor.authorAndersen, Jacob H.
dc.contributor.authorSaastamoinen, Leena K.
dc.contributor.authorZoega, Helga
dc.contributor.authorSkurtveit, Svetlana Ondrasova
dc.contributor.authorWastesson, Jonas W.
dc.contributor.authorHallas, Jesper
dc.contributor.authorPottegård, Anton
dc.date.accessioned2023-01-09T08:47:25Z
dc.date.available2023-01-09T08:47:25Z
dc.date.created2022-12-01T13:48:27Z
dc.date.issued2022
dc.identifier.citationBasic & Clinical Pharmacology & Toxicology. 2022, 132 (1), 60-70.
dc.identifier.issn1742-7835
dc.identifier.urihttps://hdl.handle.net/11250/3041780
dc.language.isoeng
dc.titleUse of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020
dc.title.alternativeUse of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber60-70
dc.source.volume132
dc.source.journalBasic & Clinical Pharmacology & Toxicology
dc.source.issue1
dc.identifier.doi10.1111/bcpt.13811
dc.identifier.cristin2087116
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel